Khot Sandeep P, Davis Arielle P, Crane Deborah A, Tanzi Patricia M, Lue Denise Li, Claflin Edward S, Becker Kyra J, Longstreth W T, Watson Nathaniel F, Billings Martha E
Department of Neurology, Division of Pulmonary and Critical Care Medicine, University of Washington School of Medicine, Seattle, WA.
Department of Physical Medicine and Rehabilitation, Division of Pulmonary and Critical Care Medicine, University of Washington School of Medicine, Seattle, WA.
J Clin Sleep Med. 2016 Jul 15;12(7):1019-26. doi: 10.5664/jcsm.5940.
Obstructive sleep apnea (OSA) predicts poor functional outcome after stroke and increases the risk for recurrent stroke. Less is known about continuous positive airway pressure (CPAP) treatment on stroke recovery.
In a pilot randomized, double-blind, sham-controlled trial, adult stroke rehabilitation patients were assigned to auto-titrating or sham CPAP without diagnostic testing for OSA. Change in Functional Independence Measure (FIM), a measure of disability, was assessed between rehabilitation admission and discharge.
Over 18 months, 40 patients were enrolled and 10 withdrew from the study: 7 from active and 3 from sham CPAP (p > 0.10). For the remaining 30 patients, median duration of CPAP use was 14 days. Average CPAP use was 3.7 h/night, with at least 4 h nightly use among 15 patients. Adherence was not influenced by treatment assignment or stroke severity. In intention-to-treat analyses (n = 40), the median change in FIM favored active CPAP over sham but did not reach statistical significance (34 versus 26, p = 0.25), except for the cognitive component (6 versus 2.5, p = 0.04). The on-treatment analyses (n = 30) yielded similar results (total FIM: 32 versus 26, p = 0.11; cognitive FIM: 6 versus 2, p = 0.06).
A sham-controlled CPAP trial among stroke rehabilitation patients was feasible in terms of recruitment, treatment without diagnostic testing and adequate blinding-though was limited by study retention and CPAP adherence. Despite these limitations, a trend towards a benefit of CPAP on recovery was evident. Tolerance and adherence must be improved before the full benefits of CPAP on recovery can be assessed in larger trials.
阻塞性睡眠呼吸暂停(OSA)预示着中风后功能恢复不良,并增加中风复发风险。关于持续气道正压通气(CPAP)治疗对中风恢复的影响,人们了解较少。
在一项初步的随机、双盲、假对照试验中,成年中风康复患者被分配接受自动调压CPAP或假CPAP治疗,且未进行OSA诊断测试。在康复入院和出院之间评估功能独立性测量(FIM)的变化,这是一种残疾程度的测量方法。
在18个月的时间里,共招募了40名患者,10名退出研究:7名来自接受积极治疗组,3名来自假CPAP组(p>0.10)。对于其余30名患者,CPAP使用的中位持续时间为14天。平均每晚使用CPAP的时间为3.7小时,15名患者每晚至少使用4小时。依从性不受治疗分配或中风严重程度的影响。在意向性分析(n = 40)中,FIM的中位变化有利于积极CPAP治疗组而非假治疗组,但未达到统计学意义(分别为34和26,p = 0.25),认知部分除外(分别为6和2.5,p = 0.04)。治疗中分析(n = 30)得出了类似的结果(总FIM:32和26,p = 0.11;认知FIM:6和2,p = 0.06)。
在中风康复患者中进行的假对照CPAP试验在招募、无需诊断测试的治疗以及充分的盲法方面是可行的——尽管受到研究保留率和CPAP依从性的限制。尽管有这些限制,CPAP对恢复有益的趋势很明显。在更大规模的试验中评估CPAP对恢复的全部益处之前,必须提高耐受性和依从性。